C H Chau
Overview
Explore the profile of C H Chau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chan A, Chan M, Yip P, Yam W, Chau C, Lam R, et al.
Hong Kong Med J
. 2023 Feb;
29(1):70-72.
PMID: 36810242
No abstract available.
2.
Leung E, Leung C, Chang K, Chan C, Mok T, Chan K, et al.
Hong Kong Med J
. 2018 Aug;
24(4):361-368.
PMID: 30065120
Objective: To assess the risk factors and effects of delayed diagnosis on tuberculosis (TB) mortality in Hong Kong. Methods: All consecutive patients with TB notified in 2010 were tracked through...
3.
Benazzi C, Al-Dissi A, Chau C, Figg W, Sarli G, de Oliveira J, et al.
ScientificWorldJournal
. 2014 Feb;
2014:919570.
PMID: 24563633
Blood supply is essential for development and growth of tumors and angiogenesis is the fundamental process of new blood vessel formation from preexisting ones. Angiogenesis is a prognostic indicator for...
4.
Lee J, Tsui K, Cheung C, Chau C, Chan H, Wu K, et al.
Hong Kong Med J
. 2013 May;
19(3):207-13.
PMID: 23650199
OBJECTIVE. To assess the efficacy and safety of aspirin desensitisation in Chinese patients with coronary artery disease. DESIGN. Case series. SETTING. A regional hospital in Hong Kong. PATIENTS. Chinese patients...
5.
Wu K, Tsui K, Lee K, Chau C, Chan H, Cheung S, et al.
Hong Kong Med J
. 2012 Aug;
18(4):276-83.
PMID: 22865170
OBJECTIVES. To review the 10-year trend of reperfusion strategies in patients with ST-segment elevation myocardial infarction, and the adoption rate of percutaneous coronary interventions as opposed to thrombolytic therapy. Also...
6.
Cheung G, Tsui K, Lau C, Chan H, Chau C, Wu K, et al.
Hong Kong Med J
. 2010 Oct;
16(5):347-53.
PMID: 20889998
Objective: To review primary percutaneous coronary interventions performed for patients with ST elevation myocardial infarction with a focus on door-to-treatment time, especially after introduction of a new management programme in...
7.
8.
Analyses of fluoroquinolones and Clostridium difficile-associated diarrhoea in tuberculosis patients
Chang K, Leung C, Yew W, Lam F, Ho P, Chau C, et al.
Int J Tuberc Lung Dis
. 2009 Mar;
13(3):341-6.
PMID: 19275794
Setting: Systematic studies of fluoroquinolones (FQs) and Clostridium difficile-associated diarrhoea (CDAD) are scarce among tuberculosis (TB) patients, in whom fluoroquinolones (FQs) are increasingly used. Objective: To evaluate the relationship between...
9.
Yew W, Chau C, Wen K
Int J Tuberc Lung Dis
. 2008 Feb;
12(3):345-6.
PMID: 18284844
No abstract available.
10.
Yau K, Siu W, Wong D, Chau C, Li A, Law B, et al.
Dis Esophagus
. 2007 Oct;
20(6):487-90.
PMID: 17958723
Primary small cell carcinoma of the esophagus (SmCC) is an uncommon aggressive tumor characterized by early systemic dissemination and poor prognosis, regardless of the methods of treatment. The optimal treatment...